alendronate has been researched along with Thyroid Neoplasms in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the effect of antibone resorptive agents, in particular alendronate (ALN) on BMD in postmenopausal osteoporotic women with thyroid carcinoma who were receiving long-term thyrotropin (TSH)-suppressive therapy with thyroxine." | 3.75 | Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. ( Assante, R; Fonderico, F; Lupoli, G; Lupoli, GA; Marciello, F; Martinelli, A; Panico, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panico, A | 1 |
| Lupoli, GA | 1 |
| Fonderico, F | 1 |
| Marciello, F | 1 |
| Martinelli, A | 1 |
| Assante, R | 1 |
| Lupoli, G | 1 |
1 other study available for alendronate and Thyroid Neoplasms
| Article | Year |
|---|---|
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; | 2009 |